MXC 0.00% 4.1¢ mgc pharmaceuticals ltd

Outlook for MXC, page-195

  1. 36 Posts.
    lightbulb Created with Sketch. 6
    Overnight HGEN was denied emergency FDA use. It is a rival product aimed at treating a Cytokine storm (essentially what kills you with Covid).
    If the Phase III trials in Israel succeed MXC will become a multi billion $ product (1st to market always wins).
    HGEN was a $900m company 2 days ago, MXC is $140m.
    Massively undervalued!
 
watchlist Created with Sketch. Add MXC (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $99.33M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 166315 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 1053332 3
View Market Depth
Last trade - 11.01am 01/12/2021 (20 minute delay) ?
MXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.